These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 27895044)

  • 1. Polymorphisms in the GNAS Gene as Predictors of Ventricular Tachyarrhythmias and Sudden Cardiac Death: Results From the DISCOVERY Trial and Oregon Sudden Unexpected Death Study.
    Wieneke H; Svendsen JH; Lande J; Spencker S; Martinez JG; Strohmer B; Toivonen L; Le Marec H; Garcia-Fernandez FJ; Corrado D; Huertas-Vazquez A; Uy-Evanado A; Rusinaru C; Reinier K; Foldesi C; Hulak W; Chugh SS; Siffert W
    J Am Heart Assoc; 2016 Nov; 5(12):. PubMed ID: 27895044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms associated with ventricular tachyarrhythmias: rationale, design, and endpoints of the 'diagnostic data influence on disease management and relation of genomics to ventricular tachyarrhythmias in implantable cardioverter/defibrillator patients (DISCOVERY)' study.
    Wieneke H; Spencker S; Svendsen JH; Martinez JG; Strohmer B; Toivonen L; Le Marec H; Garcia J; Kaup B; Soykan O; Corrado D; Siffert W
    Europace; 2010 Mar; 12(3):424-9. PubMed ID: 20139118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RyR2 Common Gene Variant G1886S and the Risk of Ventricular Arrhythmias in ICD Patients with Heart Failure.
    Francia P; Adduci C; Semprini L; Stanzione R; Serdoz A; Caprinozzi M; Santini D; Cotugno M; Palano F; Musumeci MB; Rubattu S; Volpe M
    J Cardiovasc Electrophysiol; 2015 Jun; 26(6):656-61. PubMed ID: 25773045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response of right ventricular size to treatment with cardiac resynchronization therapy and the risk of ventricular tachyarrhythmias in MADIT-CRT.
    Doyle CL; Huang DT; Moss AJ; Solomon SD; Campbell P; McNitt S; Polonsky S; Barsheshet A; Aktas M; Tompkins C; Zareba W; Goldenberg I
    Heart Rhythm; 2013 Oct; 10(10):1471-7. PubMed ID: 23872690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QRS Fragmentation and QTc Duration Relate to Malignant Ventricular Tachyarrhythmias and Sudden Cardiac Death in Patients with Hypertrophic Cardiomyopathy.
    Debonnaire P; Katsanos S; Joyce E; VAN DEN Brink OV; Atsma DE; Schalij MJ; Bax JJ; Delgado V; Marsan NA
    J Cardiovasc Electrophysiol; 2015 May; 26(5):547-55. PubMed ID: 25648421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving sudden cardiac death risk stratification by evaluating electrocardiographic measures of global electrical heterogeneity and clinical outcomes among patients with implantable cardioverter-defibrillators: rationale and design for a retrospective, multicenter, cohort study.
    Waks JW; Hamilton C; Das S; Ehdaie A; Minnier J; Narayan S; Niebauer M; Raitt M; Tompkins C; Varma N; Chugh S; Tereshchenko LG
    J Interv Card Electrophysiol; 2018 Jun; 52(1):77-89. PubMed ID: 29541969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac Resynchronization Therapy Reduces Ventricular Arrhythmias in Primary but Not Secondary Prophylactic Implantable Cardioverter Defibrillator Patients: Insight From the Resynchronization in Ambulatory Heart Failure Trial.
    Sapp JL; Parkash R; Wells GA; Yetisir E; Gardner MJ; Healey JS; Thibault B; Sterns LD; Birnie D; Nery PB; Sivakumaran S; Essebag V; Dorian P; Tang AS
    Circ Arrhythm Electrophysiol; 2017 Mar; 10(3):. PubMed ID: 28292754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial.
    Ruwald MH; Solomon SD; Foster E; Kutyifa V; Ruwald AC; Sherazi S; McNitt S; Jons C; Moss AJ; Zareba W
    Circulation; 2014 Dec; 130(25):2278-86. PubMed ID: 25301831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex Differences in Device Therapies for Ventricular Arrhythmias or Death in the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) Trial.
    Tompkins CM; Kutyifa V; Arshad A; McNitt S; Polonsky B; Wang PJ; Moss AJ; Zareba W
    J Cardiovasc Electrophysiol; 2015 Aug; 26(8):862-871. PubMed ID: 25929699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implantable cardioverter defibrillator for prevention of sudden cardiac death in patients with ventricular tachycardia and ventricular fibrillation: ICD therapy in sudden cardiac death.
    Akhtar M; Jazayeri M; Sra J; Tchou P; Rovang K; Blanck Z; Dhala A; Deshpande S; Axtell K
    Pacing Clin Electrophysiol; 1993 Mar; 16(3 Pt 2):511-8. PubMed ID: 7681950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial.
    Packer DL; Prutkin JM; Hellkamp AS; Mitchell LB; Bernstein RC; Wood F; Boehmer JP; Carlson MD; Frantz RP; McNulty SE; Rogers JG; Anderson J; Johnson GW; Walsh MN; Poole JE; Mark DB; Lee KL; Bardy GH
    Circulation; 2009 Dec; 120(22):2170-6. PubMed ID: 19917887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ventricular arrhythmia following alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
    Noseworthy PA; Rosenberg MA; Fifer MA; Palacios IF; Lowry PA; Ruskin JN; Sanborn DM; Picard MH; Vlahakes GJ; Mela T; Das S
    Am J Cardiol; 2009 Jul; 104(1):128-32. PubMed ID: 19576333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of and predictors for appropriate implantable cardioverter-defibrillator therapy in patients with a secondary preventive implantable cardioverter-defibrillator indication.
    Schaer B; Kühne M; Reichlin T; Osswald S; Sticherling C
    Europace; 2016 Feb; 18(2):227-31. PubMed ID: 26063686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
    Maron BJ; Spirito P; Shen WK; Haas TS; Formisano F; Link MS; Epstein AE; Almquist AK; Daubert JP; Lawrenz T; Boriani G; Estes NA; Favale S; Piccininno M; Winters SL; Santini M; Betocchi S; Arribas F; Sherrid MV; Buja G; Semsarian C; Bruzzi P
    JAMA; 2007 Jul; 298(4):405-12. PubMed ID: 17652294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of prolonged QRS duration with ventricular tachyarrhythmias and sudden cardiac death in the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II).
    Dhar R; Alsheikh-Ali AA; Estes NA; Moss AJ; Zareba W; Daubert JP; Greenberg H; Case RB; Kent DM
    Heart Rhythm; 2008 Jun; 5(6):807-13. PubMed ID: 18534364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study.
    Whang W; Mittleman MA; Rich DQ; Wang PJ; Ruskin JN; Tofler GH; Muller JE; Albert CM;
    Circulation; 2004 Mar; 109(11):1386-91. PubMed ID: 14993132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of a curtailed randomized controlled trial, evaluating the efficacy and safety of azimilide in patients with implantable cardioverter-defibrillators: The SHIELD-2 trial.
    Robinson VM; Bharucha DB; Mahaffey KW; Dorian P; Kowey PR;
    Am Heart J; 2017 Mar; 185():43-51. PubMed ID: 28267474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Clinical Outcome of Arrhythmogenic Right Ventricular Cardiomyopathy in Individuals With a p.S358L Mutation in TMEM43 Following Implantable Cardioverter Defibrillator Therapy.
    Hodgkinson KA; Howes AJ; Boland P; Shen XS; Stuckless S; Young TL; Curtis F; Collier A; Parfrey PS; Connors SP
    Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):. PubMed ID: 26966288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.